Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients - Top-Institutions - MDSpire

Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients

  • By

  • Tomoe Ogawa

  • Hiromune Narusawa

  • Keisuke Nagasaki

  • Rika Kosaki

  • Yasuhiro Naiki

  • Michihiko Aramaki

  • Keiko Matsubara

  • Akie Nakamura

  • Maki Fukami

  • Tsutomu Ogata

  • Masayo Kagami

  • December 18, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Baylor College of Medicine
    Baylor College of Medicine

    Houston, TX

    Key Differentiators

    • Medical Genetics
    • Pediatric Endocrinology
    • Rare Disease Research

  • #2

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Endocrinology
    • Genetics
    • Neurodevelopmental Disorders

  • #3

    Tokyo Medical and Dental University (TMDU)
    Tokyo Medical and Dental University (TMDU)

    Tokyo, Tokyo Prefecture

    Key Differentiators

    • Medical Genetics
    • Pediatric Endocrinology
    • Imprinting Disorders

  • #4

    University of Cambridge, Department of Medical Genetics
    University of Cambridge, Department of Medical Genetics

    Cambridge, Cambridgeshire

    Key Differentiators

    • Medical Genetics
    • Epigenetics
    • Pediatric Endocrinology

  • #5

    National Institute of Child Health and Human Development (NICHD), NIH
    National Institute of Child Health and Human Development (NICHD), NIH

    Bethesda, MD

    Key Differentiators

    • Pediatric Endocrinology
    • Genetics
    • Rare Diseases

Original Source(s)

Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients

  • by Tomoe Ogawa, Hiromune Narusawa, Keisuke Nagasaki, Rika Kosaki, Yasuhiro Naiki, Michihiko Aramaki, Keiko Matsubara, Akie Nakamura, Maki Fukami, Tsutomu Ogata, Masayo Kagami

  • December 18, 2024

Related Content

Reported Knowledge of Recent HbA1c, Blood Pressure, and LDL-cholesterol Levels and Goals Among US Adults with Diabetes—National Health and Nutrition Examination Survey 2011–2020

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

An epidemiological assessment of the distribution and sociodemographic burden of chronic diseases: a focus on hypertension, diabetes, and cardiovascular conditions